204 related articles for article (PubMed ID: 15781816)
1. Gray and white matter volume changes in early RRMS: a 2-year longitudinal study.
Tiberio M; Chard DT; Altmann DR; Davies G; Griffin CM; Rashid W; Sastre-Garriga J; Thompson AJ; Miller DH
Neurology; 2005 Mar; 64(6):1001-7. PubMed ID: 15781816
[TBL] [Abstract][Full Text] [Related]
2. Brain atrophy in clinically early relapsing-remitting multiple sclerosis.
Chard DT; Griffin CM; Parker GJ; Kapoor R; Thompson AJ; Miller DH
Brain; 2002 Feb; 125(Pt 2):327-37. PubMed ID: 11844733
[TBL] [Abstract][Full Text] [Related]
3. Gray matter atrophy is related to long-term disability in multiple sclerosis.
Fisniku LK; Chard DT; Jackson JS; Anderson VM; Altmann DR; Miszkiel KA; Thompson AJ; Miller DH
Ann Neurol; 2008 Sep; 64(3):247-54. PubMed ID: 18570297
[TBL] [Abstract][Full Text] [Related]
4. Exploring the effect of glatiramer acetate on cerebral gray matter atrophy in multiple sclerosis.
AbdelRazek MA; Tummala S; Khalid F; Tauhid S; Jalkh Y; Khalil S; Hurwitz S; Zurawski J; Bakshi R
J Neurol Sci; 2023 Jan; 444():120501. PubMed ID: 36481574
[TBL] [Abstract][Full Text] [Related]
5. Evidence for progressive gray matter loss in patients with relapsing-remitting MS.
Valsasina P; Benedetti B; Rovaris M; Sormani MP; Comi G; Filippi M
Neurology; 2005 Oct; 65(7):1126-8. PubMed ID: 16217074
[TBL] [Abstract][Full Text] [Related]
6. Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis: A retrospective analysis.
Fisher E; Nakamura K; Lee JC; You X; Sperling B; Rudick RA
Mult Scler; 2016 Apr; 22(5):668-76. PubMed ID: 26238463
[TBL] [Abstract][Full Text] [Related]
7. Brain atrophy and lesion load in a large population of patients with multiple sclerosis.
Tedeschi G; Lavorgna L; Russo P; Prinster A; Dinacci D; Savettieri G; Quattrone A; Livrea P; Messina C; Reggio A; Bresciamorra V; Orefice G; Paciello M; Brunetti A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Patti F; Salemi G; Cammarata E; Simone IL; Salvatore M; Bonavita V; Alfano B
Neurology; 2005 Jul; 65(2):280-5. PubMed ID: 16043800
[TBL] [Abstract][Full Text] [Related]
8. Gray matter atrophy in multiple sclerosis: a longitudinal study.
Fisher E; Lee JC; Nakamura K; Rudick RA
Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
[TBL] [Abstract][Full Text] [Related]
9. Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis.
Sastre-Garriga J; Ingle GT; Chard DT; Ramió-Torrentà L; Miller DH; Thompson AJ
Neuroimage; 2004 May; 22(1):353-9. PubMed ID: 15110026
[TBL] [Abstract][Full Text] [Related]
10. White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
Mühlau M; Buck D; Förschler A; Boucard CC; Arsic M; Schmidt P; Gaser C; Berthele A; Hoshi M; Jochim A; Kronsbein H; Zimmer C; Hemmer B; Ilg R
Mult Scler; 2013 Oct; 19(11):1485-92. PubMed ID: 23462349
[TBL] [Abstract][Full Text] [Related]
11. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.
Oreja-Guevara C; Rovaris M; Iannucci G; Valsasina P; Caputo D; Cavarretta R; Sormani MP; Ferrante P; Comi G; Filippi M
Arch Neurol; 2005 Apr; 62(4):578-84. PubMed ID: 15824256
[TBL] [Abstract][Full Text] [Related]
12. Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy.
Zivadinov R; Locatelli L; Cookfair D; Srinivasaraghavan B; Bertolotto A; Ukmar M; Bratina A; Maggiore C; Bosco A; Grop A; Catalan M; Zorzon M
Mult Scler; 2007 May; 13(4):490-501. PubMed ID: 17463072
[TBL] [Abstract][Full Text] [Related]
13. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.
Boster A; Hreha S; Berger JR; Bao F; Penmesta R; Tselis A; Endress C; Zak I; Perumal J; Caon C; Vazquez J; Tyler KL; Racke MK; Millis S; Khan O
Arch Neurol; 2009 May; 66(5):593-9. PubMed ID: 19433659
[TBL] [Abstract][Full Text] [Related]
14. Spatiotemporal distribution pattern of white matter lesion volumes and their association with regional grey matter volume reductions in relapsing-remitting multiple sclerosis.
Bendfeldt K; Blumhagen JO; Egger H; Loetscher P; Denier N; Kuster P; Traud S; Mueller-Lenke N; Naegelin Y; Gass A; Hirsch J; Kappos L; Nichols TE; Radue EW; Borgwardt SJ
Hum Brain Mapp; 2010 Oct; 31(10):1542-55. PubMed ID: 20108225
[TBL] [Abstract][Full Text] [Related]
15. Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.
Rudick RA; Lee JC; Nakamura K; Fisher E
J Neurol Sci; 2009 Jul; 282(1-2):106-11. PubMed ID: 19100997
[TBL] [Abstract][Full Text] [Related]
16. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.
Calabrese M; Rocca MA; Atzori M; Mattisi I; Favaretto A; Perini P; Gallo P; Filippi M
Ann Neurol; 2010 Mar; 67(3):376-83. PubMed ID: 20373349
[TBL] [Abstract][Full Text] [Related]
17. Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis.
Chard DT; Griffin CM; Rashid W; Davies GR; Altmann DR; Kapoor R; Barker GJ; Thompson AJ; Miller DH
Mult Scler; 2004 Aug; 10(4):387-91. PubMed ID: 15327034
[TBL] [Abstract][Full Text] [Related]
18. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.
Calabrese M; Agosta F; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Rinaldi L; Perini P; Gallo P; Filippi M
Arch Neurol; 2009 Sep; 66(9):1144-50. PubMed ID: 19752305
[TBL] [Abstract][Full Text] [Related]
19. Multimodal MRI study on the relation between WM integrity and connected GM atrophy and its effect on disability in early multiple sclerosis.
Weeda MM; van Nederpelt DR; Twisk JWR; Brouwer I; Kuijer JPA; van Dam M; Hulst HE; Killestein J; Barkhof F; Vrenken H; Pouwels PJW
J Neurol; 2024 Jan; 271(1):355-373. PubMed ID: 37716917
[TBL] [Abstract][Full Text] [Related]
20. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study.
Bendfeldt K; Kuster P; Traud S; Egger H; Winklhofer S; Mueller-Lenke N; Naegelin Y; Gass A; Kappos L; Matthews PM; Nichols TE; Radue EW; Borgwardt SJ
Neuroimage; 2009 Mar; 45(1):60-7. PubMed ID: 19013533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]